Share

Updates matching "National"

August 7, 2022
National

Today the U.S. Senate passed the Inflation Reduction Act, which includes several provisions that will reduce the costs of health care for millions of cancer patients and survivors.

August 4, 2022
National

July 2022 – A new survey sponsored by the American Cancer Society Cancer Action Network (ACS CAN) finds many voters are tired of “just getting by” and worried about inflation and rising costs, including healthcare costs.1 Half of voters say they are putting off medical care or making other sacrifices

July 28, 2022
National

Today the U.S. Senate Appropriations Committee released its FY 2023 spending bill that includes a $2 billion funding increase for the National Institutes of Health (NIH), including a $291 million funding boost for the National Cancer Institute (NCI).

July 26, 2022
National

The Health and Human Services Department released a proposed rule Monday expanding nondiscrimination protections for patients using federally funded health programs.

July 18, 2022
National

The U.S. Court of Appeals for the Fifth Circuit ruled in favor of the U.S. Food and Drug Administration (FDA) in the case of Triton Distribution v. FDA, upholding the agency’s marketing denial order ( MDO) for Triton’s flavored e-cigarette products. 

July 18, 2022
National

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to announce the hire of a new vice president of federal affairs, and two new federal relations directors.

July 15, 2022
National

There has been huge progress in the fight against cancer. Even in just the past few years, we have seen exciting breakthroughs in cancer research and treatment. This progress is truly extraordinary – but we can’t let up.

July 11, 2022
National

A new national poll conducted by a bipartisan team of researchers for ACS CAN found 8 in 10 (81%) voters agree that the government should protect people so that they don’t lose their coverage during high inflation and economic instability.

July 5, 2022
National

An article released today in JAMA Network Open details the potential benefits of using technology to increase patient participation in cancer clinical trials. In a survey of nearly 1,200 recent cancer patients and survivors, more than 80% said they would be willing to use remote technologies and tools in a trial.